Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT04744831
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer
122 Enrollment(s)
63 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Colorectal Cancer
NOT_YET_RECRUITING
NCT07333937
Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer
35 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Brest Cancer
RECRUITING
NCT06210776
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
800 Enrollment(s)
54 Study location(s)
OBSERVATIONAL (None)
HER2-positive Breast Cancer


HER2-low Breast Cancer


Breast Cancer


Advanced Cancer
COMPLETED
NCT06961331
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.
86 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Metastatic HER2+ Advanced Breast Cancer
NOT_YET_RECRUITING
NCT07126561
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
43 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2
RECRUITING
NCT06324396
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
15 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Fontan Circulation
TERMINATED
NCT03944512
Pravastatin to Prevent Preeclampsia
102 Enrollment(s)
12 Study location(s)
INTERVENTIONAL (PHASE3)
Preeclampsia


Obstetric Labor Complications


Hypertension in Pregnancy
RECRUITING
NCT07281001
A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
HER2-positive Breast Cancer


Trastuzumab Deruxtecan